The AIDS Epidemic

Sheldon H. Landesman; Harold M. Ginzburg; Stanley H. Weiss

doi:10.1056/NEJM198502213120829

The AIDS Epidemic

Sheldon H. Landesman, Harold M. Ginzburg, Stanley H. Weiss

Research output: Contribution to journal › Article › peer-review

112 Scopus citations

Abstract

During 1984 several important developments advanced our understanding of the acquired immunodeficiency syndrome (AIDS). A retrovirus known as human T-cell leukemia (lymphotropic) virus type III (HTLV-III),¹ also called lymphadenopathy-associated virus, was identified as the probable cause of AIDS.² AIDS-associated retrovirus³ is also probably the same agent. An enzyme-linked immunosorbent assay (ELISA) has been developed to detect antibodies to HTLV-III,⁴ thereby providing an indicator of whether or not a person has been exposed to the virus. Clinical researchers have identified various therapeutic agents that appear to inhibit viral replication in vitro.^5,6 Although the ultimate goal of all these research activities is.

Original language	English (US)
Pages (from-to)	521-525
Number of pages	5
Journal	New England Journal of Medicine
Volume	312
Issue number	8
DOIs	https://doi.org/10.1056/NEJM198502213120829
State	Published - Feb 21 1985
Externally published	Yes

All Science Journal Classification (ASJC) codes

General Medicine

Access to Document

10.1056/NEJM198502213120829

Cite this

@article{485140e93eca4a3dac82018e8ed3adb4,

title = "The AIDS Epidemic",

abstract = "During 1984 several important developments advanced our understanding of the acquired immunodeficiency syndrome (AIDS). A retrovirus known as human T-cell leukemia (lymphotropic) virus type III (HTLV-III),1 also called lymphadenopathy-associated virus, was identified as the probable cause of AIDS.2 AIDS-associated retrovirus3 is also probably the same agent. An enzyme-linked immunosorbent assay (ELISA) has been developed to detect antibodies to HTLV-III,4 thereby providing an indicator of whether or not a person has been exposed to the virus. Clinical researchers have identified various therapeutic agents that appear to inhibit viral replication in vitro.5,6 Although the ultimate goal of all these research activities is.",

author = "Landesman, {Sheldon H.} and Ginzburg, {Harold M.} and Weiss, {Stanley H.}",

year = "1985",

month = feb,

day = "21",

doi = "10.1056/NEJM198502213120829",

language = "English (US)",

volume = "312",

pages = "521--525",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "8",

}

TY - JOUR

T1 - The AIDS Epidemic

AU - Landesman, Sheldon H.

AU - Ginzburg, Harold M.

AU - Weiss, Stanley H.

PY - 1985/2/21

Y1 - 1985/2/21

N2 - During 1984 several important developments advanced our understanding of the acquired immunodeficiency syndrome (AIDS). A retrovirus known as human T-cell leukemia (lymphotropic) virus type III (HTLV-III),1 also called lymphadenopathy-associated virus, was identified as the probable cause of AIDS.2 AIDS-associated retrovirus3 is also probably the same agent. An enzyme-linked immunosorbent assay (ELISA) has been developed to detect antibodies to HTLV-III,4 thereby providing an indicator of whether or not a person has been exposed to the virus. Clinical researchers have identified various therapeutic agents that appear to inhibit viral replication in vitro.5,6 Although the ultimate goal of all these research activities is.

AB - During 1984 several important developments advanced our understanding of the acquired immunodeficiency syndrome (AIDS). A retrovirus known as human T-cell leukemia (lymphotropic) virus type III (HTLV-III),1 also called lymphadenopathy-associated virus, was identified as the probable cause of AIDS.2 AIDS-associated retrovirus3 is also probably the same agent. An enzyme-linked immunosorbent assay (ELISA) has been developed to detect antibodies to HTLV-III,4 thereby providing an indicator of whether or not a person has been exposed to the virus. Clinical researchers have identified various therapeutic agents that appear to inhibit viral replication in vitro.5,6 Although the ultimate goal of all these research activities is.

UR - http://www.scopus.com/inward/record.url?scp=0021918306&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021918306&partnerID=8YFLogxK

U2 - 10.1056/NEJM198502213120829

DO - 10.1056/NEJM198502213120829

M3 - Article

C2 - 2982097

AN - SCOPUS:0021918306

SN - 0028-4793

VL - 312

SP - 521

EP - 525

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 8

ER -

The AIDS Epidemic

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this